National Institutes of Health

Description

This Funding Opportunity Announcement (FOA) solicits Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose the advanced stage development of pharmacological treatment agents for drug and nicotine abuse and dependence. This FOA specifically invites applications for the competing renewal (formerly competing continuation ) of previously funded Phase II SBIR grants, to take existing, promising compounds through the next step of drug discovery and development.

Who can apply

• Small businesses
• Others

Contact

If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV